Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
68.8M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
22.1M
-
Shares change
-
+1.41M
-
Total reported value, excl. options
-
$230M
-
Value change
-
+$15M
-
Put/Call ratio
-
0.24
-
Number of buys
-
29
-
Number of sells
-
-25
-
Price
-
$10.42
Significant Holders of EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (EYPT) as of Q3 2021
76 filings reported holding EYPT - EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
EyePoint Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (EYPT) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.1M shares
of 68.8M outstanding shares and own 32.14% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4.19M shares), FRANKLIN RESOURCES INC (3.17M shares), RA CAPITAL MANAGEMENT, L.P. (2.21M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.76M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.7M shares), BlackRock Inc. (1.19M shares), VANGUARD GROUP INC (1.09M shares), CITADEL ADVISORS LLC (946K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (751K shares), and JANUS HENDERSON GROUP PLC (712K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.